Dr. Farchoukh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
200 Lothrop st
UPMC department of pathology
Oakland, PA 15213- Is this information wrong?
Summary
- Dr. Lama Farchoukh is a pathologist in Pittsburgh, PA and is affiliated with University of Pittsburgh Medical Center
Education & Training
UPMC Medical Education (Presbyterian Shadyside Hospital) AFellowship, Selective Pathology, 2019 - 2020- UPMC Medical EducationFellowship, Cytopathology, 2018 - 2019
- UPMC Medical EducationChief Residency, Pathology-Anatomic and Clinical, 2016 - 2018
- UPMC Medical EducationResidency, Pathology-Anatomic and Clinical, 2014 - 2018
American University of Beirut Faculty of MedicineClass of 2009
American University of BeirutBS, Chemistry, Distinction, 2002 - 2005
Certifications & Licensure
PA State Medical License 2014 - 2024
NY State Medical License 2019 - 2021- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
- American Board of Pathology Cytopathology
Awards, Honors, & Recognition
- Best resident poster award ASCP, 2015
Publications & Presentations
PubMed
- 3 citationsDNA Mismatch Repair-deficient Rectal Cancer Is Frequently Associated With Lynch Syndrome and With Poor Response to Neoadjuvant Therapy.Lama F Farchoukh, James Celebrezze, David Medich, Kellie Cunningham, Jennifer Holder-Murray, Matthew Holtzman, Kenneth Lee, Reetesh K Pai, Haroon Choudry> ;The American Journal of Surgical Pathology. 2022 Sep 1
- 6 citationsCombined histopathological risk score using TP53 protein expression, CD8+ T cell density and intratumoral budding is an independent predictor of neoadjuvant therapy re...Wei Chen, Lama Farchoukh, Lindsey Seigh, Douglas J. Hartman, Reetesh K. Pai> ;Histopathology. 2021 Jun 14
- 22 citationsIntratumoral budding and automated CD8-positive T-cell density in pretreatment biopsies can predict response to neoadjuvant therapy in rectal adenocarcinomaLama Farchoukh, Douglas J. Hartman, Changqing Ma, James P. Celebrezze, David S. Medich, Nathan Bahary, Madison Frank, Liron Pantanowitz, Reetesh K. Pai> ;Modern Pathology. 2021 Jan 1
- Join now to see all
Other Languages
- Arabic, French
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
